Apelian to lead new T cell company BlueSphere

With serial biotech executive David Apelian as CEO, University of Pittsburgh and UPMC spinout BlueSphere debuted Wednesday with plans to move its

Read the full 229 word article

How to gain access

Continue reading with a
two-week free trial.